查詢結果分析
來源資料
相關文獻
- 改善血液透析患者血比容積偏低專案
- The Significance of Syphilis Serology Tests on Long-Term Hemodialysis Patients
- Watermelon Stomach--An Unusual Cause of Recurrent Upper Gastrointestinal Bleeding in a Uremic Patient Receiving Estrogen-Progesterone Therapy: Case Report
- Serum Transferrin Receptor Concentration is Not Indicative of Erythropoietic Activity in Chronic Hemodialysis Patients with Poor Response to Recombinant Human Erythropoietin
- 血液透析患者飲食習慣之調查
- 血液透析動靜脈瘻管的竊血症候群
- 血液透析病人的中央靜脈狹窄
- 經皮下血管擴張術於長期血液透析病患之運用
- 血液透析患者對於服用磷結合劑在行為態度知識及副甲狀腺高能症的探討
- 血液透析處方之臨床實用準則(1)
第1筆 /總和 1 筆
/ 1 筆
頁籤選單縮合
題名 | 改善血液透析患者血比容積偏低專案=A Project to Improve Hemodialysis Patients' Low Hematocrit |
---|---|
作者 | 黃文鳳; 林品昀; 鄭金鳳; Huang, Wen-feng; Lin, Pin-jun; Cheng, Jin-feng; |
期刊 | 領導護理 |
出版日期 | 20090400 |
卷期 | 10:1 2009.04[民98.04] |
頁次 | 頁106-117 |
分類號 | 415.816 |
語文 | chi |
關鍵詞 | 血液透析; 血比容偏低; Hemodialysis; Low hematocrit; |
中文摘要 | 本專案旨在降低血液透析個案血比容積偏低的比率,經調查發現本院血液透析患者血比容積(Hematocrite,HCT)平均值爲28.7%,其中46%個案血比容積<8%,平均每人每月使用合成基因紅血球生成素(r-HuEPO)高達19000U,引發成立專案小組改善。經現況分析確立問題有:個案對貧血相關知識缺乏、個案缺乏鐵劑、個案營養不良、透析管路血液回收不全及r-HuEPO採靜脈注射而影響吸收。經由改善方案:改變r-HuEPO注射途徑、更換鐵劑廠牌改善過敏問題、舉辦貧血相關之衛教、製作衛教海報及DVD、制定透析結束收針標準。經實施上述各項改善措施後,透析個案HCT<28%者由改善前46%降至21%;r-HuEPO的使用量也由改善前平均每人使用19000U降至15712U,不但改善透析個案之貧血情形,更降低醫療成本的支出。 |
英文摘要 | An investigation showed that the average hematocrit (HCT) of the dialysis patients in this hospital was 28.7%, and 46% of the patients actually had a HCT lower than 28%. The average dosage of r-HuEPO administered per hemodialysis patient per month was as high as 19000U. The aim of a designed improvement project was to decrease the percentage rate of hemodialysis patients with low HCT (HCT < 28%). The identified problems based on data analysis included insufficient iron supplement for patients receiving hemodialysis, patients' lack of knowledge about anemia, patients' poor nutritional status, incomplete blood transfusion return from the dialysis catheters, and patient's' poor absorption of r-HuEPO via intravenous route. The designed improvementmeasures changed the injection route for r-HuEPO administration, changed the brand of iron supplement to eliminate allergy, provided educational seminars on anemia, produced educational posters and DVD's, and established the procedure standards for the closure of hemodialysis. Since the above measures were implemented, the percentage of patients with low HCT had been reduced from 46% to 21%. The average dosage of r-HuEPO administered for hemodialysis patients had been reduced from 19000U to 15712U per patient per month. The project not only improved patients' anemic status, but also reduced the medical costs. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。